Drugs / 99mTechnetium Sestamibi
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07439133 | Nov 2025 → Jun 2027 expected | coronary artery disorder | Sinotau Pharmaceutical Group | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTechnetium Sestamibi | “99mTechnetium Sestamibi as the Active Comparator” NCT07439133 ↗ |
| Known as | Drug: 99mTechnicium Sestamibi | “Drug: 99mTechnicium Sestamibi” NCT07439133 ↗ |